Physician

Soloman Shah, M.D.

According to 2025 Medicare claims, Soloman Shah, M.D. (NPI: 1578524997) practices gastroenterology in the Winchester, VA-WV market, with the plurality of this provider's patient population coming from Winchester City, VA. This provider's primary affiliated billing organization is WINCHESTER GASTROENTEROLOGY ASSOCIATES (NPI: 1740248525; TIN: 541519210) and primary practice location at 22601-2872. Shah is affiliated with the Privia Quality Network, LLC (ACO ID: A2057), ACO West Virginia (ACO ID: A3563), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 672 traditional Medicare patients, billed 7,472 HCPCS/CPT codes, and received $242,501 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 643 prescription claims across 212 beneficiaries totaling $120,814 in drug costs, led by Xifaxan (Rifaximin). Open Payments data shows 105 records totaling $1,496. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $114,810 and ending at $242,501. Concurrently, Part D prescription costs have declined steadily, from $277,932 to $120,814. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	539	997	$114,810
2016	578	1,073	$116,228
2017	760	1,378	$149,916
2018	808	1,470	$158,832
2019	826	1,319	$142,822
2020	800	1,518	$162,604
2021	782	1,726	$142,949
2022	572	1,256	$105,568
2023	262	421	$40,083
2024	672	7,472	$242,501

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	98	395	$277,932
2016	107	427	$253,494
2017	88	340	$225,033
2018	102	358	$267,685
2019	90	300	$232,266
2020	108	312	$238,362
2021	132	400	$229,962
2022	129	481	$258,837
2023	118	397	$154,835
2024	212	643	$120,814

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	91	91	$198
45380	Biopsy of large bowel using a flexible endoscope	170	170	$123
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	61	61	$109
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	145	148	$99
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	169	181	$81

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xifaxan	Rifaximin	11	330	$62,696
Mesalamine	Mesalamine	14	686	$6,222
Cholestyramine	Cholestyramine (With Sugar)	28	1,417	$4,098
Sucralfate	Sucralfate	13	421	$3,360
Pantoprazole Sodium	Pantoprazole Sodium	278	13,117	$2,815

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	105	$1,496	Salix Pharmaceuticals, a division of Bausch Health US, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Soloman Shah, M.D.?

Tedicare shows public-source Medicare data for Soloman Shah, M.D. (NPI 1578524997), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Soloman Shah, M.D. have ACO affiliation data?

Soloman Shah, M.D. is shown with ACO affiliation data for Privia Quality Network, LLC (MSSP, ACO ID A2057), ACO West Virginia (MSSP, ACO ID A3563), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Soloman Shah, M.D.?

Soloman Shah, M.D. is linked to WINCHESTER GASTROENTEROLOGY ASSOCIATES (billing NPI 1740248525) in the available physician profile data.

Does Soloman Shah, M.D. have Open Payments data?

Soloman Shah, M.D. has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.